[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@vjoncology Avatar](https://lunarcrush.com/gi/w:26/cr:youtube::UCn3u5oMgE00_qIex2IzGjYg.png) @vjoncology VJOncology

VJOncology posts on YouTube about nct, university of, germany, rates the most. They currently have XXXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/youtube::UCn3u5oMgE00_qIex2IzGjYg/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:youtube::UCn3u5oMgE00_qIex2IzGjYg/c:line/m:interactions.svg)

- X Week XXXXX +1,157%
- X Month XXXXX -X%
- X Months XXXXXX +24%
- X Year XXXXXX +0.38%

### Mentions: XX [#](/creator/youtube::UCn3u5oMgE00_qIex2IzGjYg/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:youtube::UCn3u5oMgE00_qIex2IzGjYg/c:line/m:posts_active.svg)

- X Week XX +412%
- X Month XXX -XX%
- X Months XXX +58%
- X Year XXXXX +332%

### Followers: XXXXXX [#](/creator/youtube::UCn3u5oMgE00_qIex2IzGjYg/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:youtube::UCn3u5oMgE00_qIex2IzGjYg/c:line/m:followers.svg)

- X Week XXXXXX +0.65%
- X Month XXXXXX +1.30%
- X Months XXXXXX +7.60%
- X Year XXXXXX +20%

### CreatorRank: XXXXXXXXX [#](/creator/youtube::UCn3u5oMgE00_qIex2IzGjYg/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:youtube::UCn3u5oMgE00_qIex2IzGjYg/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/youtube::UCn3u5oMgE00_qIex2IzGjYg/influence)
---

**Social category influence**
[countries](/list/countries)  XXXXX% [travel destinations](/list/travel-destinations)  XXXXX% [currencies](/list/currencies)  XXX%

**Social topic influence**
[nct](/topic/nct) #667, [university of](/topic/university-of) #1221, [germany](/topic/germany) 6.9%, [rates](/topic/rates) #1686, [australia](/topic/australia) 3.45%, [sydney](/topic/sydney) #1685, [iii](/topic/iii) 3.45%, [italy](/topic/italy) 3.45%, [london](/topic/london) 3.45%, [events](/topic/events) XXX%
### Top Social Posts [#](/creator/youtube::UCn3u5oMgE00_qIex2IzGjYg/posts)
---
Top posts by engagements in the last XX hours

"Melanoma at ESMO 2025: SWOG S1801 NADINA and more"  
[YouTube Link](https://youtube.com/watch?v=76Gn2EgcAUE) [@vjoncology](/creator/youtube/vjoncology) 2025-10-19T09:32Z 15.6K followers, XX engagements


"Highlights from ESMO 2025"  
[YouTube Link](https://youtube.com/watch?v=W4ZKV5TLcPk) [@VJOncology](/creator/youtube/VJOncology) 2025-10-24T16:18Z 15.6K followers, XX engagements


"OBP101JP: final results of oncolytic virotherapy + suratadenoturev + RT for esophageal cancer"  
[YouTube Link](https://youtube.com/watch?v=cj1qZ5IPko0) [@vjoncology](/creator/youtube/vjoncology) 2025-10-20T15:23Z 15.6K followers, XXX engagements


"NIFTY: liposomal irinotecan in combination with 5FU and leucovorin in patients with mBTC"  
[YouTube Link](https://youtube.com/watch?v=0YuQ6PNvl_g) [@VJOncology](/creator/youtube/VJOncology) 2021-07-08T15:02Z 15.6K followers, XXX engagements


"PSMAddition: 177Lu-PSMA-617 plus ADT and ARPI in PSMA-positive mHSPC"  
[YouTube Link](https://youtube.com/watch?v=PKEJ1xtMCBQ) [@VJOncology](/creator/youtube/VJOncology) 2025-10-21T13:09Z 15.6K followers, XX engagements


"EMBARK: final OS results of enzalutamide in hrBCR prostate cancer"  
[YouTube Link](https://youtube.com/watch?v=rVgkdIr5FBw) [@vjoncology](/creator/youtube/vjoncology) 2025-10-20T11:49Z 15.6K followers, XX engagements


"OptiTROP-Lung04: sacituzumab tirumotecan in EGFR-mutated NSCLC"  
[YouTube Link](https://youtube.com/watch?v=3D8hQZNDe-Y) [@vjoncology](/creator/youtube/vjoncology) 2025-10-23T16:15Z 15.6K followers, XX engagements


"5-year follow-up of CheckMate 648: NIVO plus chemo or IPI vs chemo as 1L treatment for advanced ESCC"  
[YouTube Link](https://youtube.com/watch?v=4av3F4uNYPg) [@vjoncology](/creator/youtube/vjoncology) 2025-10-20T13:36Z 15.6K followers, XX engagements


"FORAGER-1: dose optimization of LY3866288 in FGFR3-altered tumors"  
[YouTube Link](https://youtube.com/watch?v=8KRENmnchO8) [@vjoncology](/creator/youtube/vjoncology) 2025-10-22T09:59Z 15.6K followers, XX engagements


"NIAGARA: HRQoL outcomes of perioperative durvalumab in MIBC"  
[YouTube Link](https://youtube.com/watch?v=9nD9kGK2Pgk) [@vjoncology](/creator/youtube/vjoncology) 2025-10-22T10:50Z 15.6K followers, XX engagements


"The potential of spatial biology & clonal evolution mapping to transform precision cancer treatment"  
[YouTube Link](https://youtube.com/watch?v=EIQxxTHivnQ) [@VJOncology](/creator/youtube/VJOncology) 2025-10-20T17:52Z 15.6K followers, XX engagements


"Capturing clonal evolution of ccRCC through histology"  
[YouTube Link](https://youtube.com/watch?v=HweaK5uF1wQ) [@vjoncology](/creator/youtube/vjoncology) 2025-10-20T17:43Z 15.6K followers, XX engagements


"Practice-changing CRC cancer trials at ASCO 2025: ATOMIC & CheckMate 8HW"  
[YouTube Link](https://youtube.com/watch?v=JBE8kfGzQj4) [@VJOncology](/creator/youtube/VJOncology) 2025-06-05T10:46Z 15.6K followers, XXX engagements


"Three vs six cycles of platinum-based chemotherapy for aUC in the DISCUS trial"  
[YouTube Link](https://youtube.com/watch?v=JML3v6NawRM) [@vjoncology](/creator/youtube/vjoncology) 2025-10-23T16:18Z 15.6K followers, XX engagements


"ENZARAD: enzalutamide with ADT and radiation in high-risk prostate cancer"  
[YouTube Link](https://youtube.com/watch?v=L6sB-uV1wbM) [@vjoncology](/creator/youtube/vjoncology) 2025-10-23T11:28Z 15.6K followers, XX engagements


"Neoadjuvant nivolumab with or without visugromab in cisplatin-ineligible MIBC"  
[YouTube Link](https://youtube.com/watch?v=LIUEYok9c_g) [@vjoncology](/creator/youtube/vjoncology) 2025-10-23T16:36Z 15.6K followers, XX engagements


"IMvigor011: ctDNA-guided adjuvant atezolizumab in MIBC"  
[YouTube Link](https://youtube.com/watch?v=Mu4eFZAPxkw) [@vjoncology](/creator/youtube/vjoncology) 2025-10-22T12:58Z 15.6K followers, XX engagements


"Management of interstitial lung disease in the DESTINY-Breast05 trial"  
[YouTube Link](https://youtube.com/watch?v=P2iPlS1lFFw) [@vjoncology](/creator/youtube/vjoncology) 2025-10-22T12:55Z 15.6K followers, XX engagements


"CARES-009: perioperative camrelizumab and rivoceranib in resectable HCC"  
[YouTube Link](https://youtube.com/watch?v=Q1xNps3ZxyQ) [@vjoncology](/creator/youtube/vjoncology) 2025-10-23T11:56Z 15.6K followers, XX engagements


"DESTINY-Breast05: T-DXd vs T-DM1 in high-risk HER2+ early breast cancer"  
[YouTube Link](https://youtube.com/watch?v=R3C9KfnZ1EE) [@vjoncology](/creator/youtube/vjoncology) 2025-10-22T12:53Z 15.6K followers, XX engagements


"CheckMate 8HW: nivolumab & ipilimumab in MSI-H/dMMR metastatic CRC"  
[YouTube Link](https://youtube.com/watch?v=UzupwedDjuI) [@vjoncology](/creator/youtube/vjoncology) 2025-10-22T14:36Z 15.6K followers, XX engagements


"BURAN: buparlisib and paclitaxel in pre-treated HNSCC"  
[YouTube Link](https://youtube.com/watch?v=XEoMSmRWaaw) [@vjoncology](/creator/youtube/vjoncology) 2025-10-23T16:56Z 15.6K followers, XX engagements


"DISCUS: comparing X vs X chemotherapy cycles before avelumab in aUC"  
[YouTube Link](https://youtube.com/watch?v=_z8Y2ysRCwQ) [@vjoncology](/creator/youtube/vjoncology) 2025-10-22T10:09Z 15.6K followers, XX engagements


"First line IO102-IO103 vaccine plus pembrolizumab in advanced melanoma"  
[YouTube Link](https://youtube.com/watch?v=aX6bpZDesCQ) [@vjoncology](/creator/youtube/vjoncology) 2025-10-23T11:26Z 15.6K followers, XX engagements


"SWOG S1801: 3-year outcomes of neoadjuvant-adjuvant pembrolizumab"  
[YouTube Link](https://youtube.com/watch?v=exJeDv0uzTk) [@vjoncology](/creator/youtube/vjoncology) 2025-10-20T14:07Z 15.6K followers, XX engagements


"PATHFINDER II: assessing the efficacy and safety of a MCAD test"  
[YouTube Link](https://youtube.com/watch?v=jqwOhq7fRDA) [@vjoncology](/creator/youtube/vjoncology) 2025-10-23T16:13Z 15.6K followers, XX engagements


"RC48-C016: disitamab vedotin & toripalimab vs chemotherapy in HER2+ la/mUC"  
[YouTube Link](https://youtube.com/watch?v=rucT4oIVunU) [@vjoncology](/creator/youtube/vjoncology) 2025-10-22T10:48Z 15.6K followers, XX engagements


"IMbrave152/SKYSCRAPER-14: tiragolumab atezolizumab & bevacizumab in HCC"  
[YouTube Link](https://youtube.com/watch?v=s59zrSVcaD4) [@vjoncology](/creator/youtube/vjoncology) 2025-10-23T11:55Z 15.6K followers, XX engagements


"OPTIC RCC: efficacy of cabozantinib and nivolumab in cluster 1/2 metastatic ccRCC"  
[YouTube Link](https://youtube.com/watch?v=sbkc7DrEPEQ) [@vjoncology](/creator/youtube/vjoncology) 2025-10-20T17:28Z 15.6K followers, XX engagements


"ASCO 2025 highlights in breast cancer: ASCENT-04 SERENA-6 and more"  
[YouTube Link](https://youtube.com/watch?v=wDk_Bmjg0fo) [@vjoncology](/creator/youtube/vjoncology) 2025-07-28T11:28Z 15.6K followers, XXX engagements


"COSMIC-313: transcriptomic predictors of metastatic sites in RCC"  
[YouTube Link](https://youtube.com/watch?v=waG80H8q1ZE) [@vjoncology](/creator/youtube/vjoncology) 2025-10-23T16:36Z 15.6K followers, XX engagements


"Comparing atezolizumab & bevacizumab with STRIDE in advanced HCC"  
[YouTube Link](https://youtube.com/watch?v=yN20SWs1R-U) [@vjoncology](/creator/youtube/vjoncology) 2025-08-21T15:23Z 15.6K followers, XXX engagements


"Gut and oral microbiomes linked to chemotherapy outcomes in GI cancer"  
[YouTube Link](https://youtube.com/watch?v=yhj-Vg7S9PI) [@vjoncology](/creator/youtube/vjoncology) 2025-10-23T16:58Z 15.6K followers, XX engagements